FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996887331> ?p ?o ?g. }

• W1996887331 endingPage "1046" @default.
• W1996887331 startingPage "1037" @default.
• W1996887331 abstract "We have published previously a prototype of a decision model for anaemic patients with myelodysplastic syndromes (MDS), in which transfusion need and serum erythropoietin (S-Epo) were used to define three groups with different probabilities of erythroid response to treatment with granulocyte colony-stimulating factor (G-CSF) + Epo. S-Epo </= 500 U/l and a transfusion need of < 2 units/month predicted a high probability of response to treatment, S-Epo > 500 U/l and >/= 2 units/month for a poor response, whereas the presence of only one negative prognostic marker predicted an intermediate response. A total of 53 patients from a prospective study were included in our evaluation sample. Patients with good or intermediate probability of response were treated with G-CSF + Epo. The overall response rate was 42% with 28.3% achieving a complete and 13.2% a partial response to treatment. The response rates were 61% and 14% in the good and intermediate predictive groups respectively. The model retained a significant predictive value in the evaluation sample (P < 0.001). Median duration of response was 23 months. Scores for global health and quality of life (QOL) were significantly lower in MDS patients than in a reference population, and fatigue and dyspnoea was significantly more prominent. Global QOL improved in patients responding to treatment (P = 0.01). The validated decision model defined a subgroup of patients with a response rate of 61% (95% confidence interval 48-74%) to treatment with G-CSF + Epo. The majority of these patients have shown complete and durable responses." @default.
• W1996887331 created "2016-06-24" @default.
• W1996887331 creator A5003907527 @default.
• W1996887331 creator A5014693569 @default.
• W1996887331 creator A5017777711 @default.
• W1996887331 creator A5020591121 @default.
• W1996887331 creator A5022052738 @default.
• W1996887331 creator A5031248010 @default.
• W1996887331 creator A5032434426 @default.
• W1996887331 creator A5033506735 @default.
• W1996887331 creator A5034029591 @default.
• W1996887331 creator A5044295563 @default.
• W1996887331 creator A5045191082 @default.
• W1996887331 creator A5049750813 @default.
• W1996887331 creator A5050171154 @default.
• W1996887331 creator A5067454281 @default.
• W1996887331 creator A5068471072 @default.
• W1996887331 creator A5070612759 @default.
• W1996887331 creator A5079834047 @default.
• W1996887331 creator A5080988408 @default.
• W1996887331 creator A5081919656 @default.
• W1996887331 creator A5082869425 @default.
• W1996887331 date "2003-03-01" @default.
• W1996887331 modified "2023-10-18" @default.
• W1996887331 title "A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life" @default.
• W1996887331 cites W1490088646 @default.
• W1996887331 cites W1541533982 @default.
• W1996887331 cites W187238933 @default.
• W1996887331 cites W1931544110 @default.
• W1996887331 cites W1947168884 @default.
• W1996887331 cites W1970838494 @default.
• W1996887331 cites W1977998150 @default.
• W1996887331 cites W1979820704 @default.
• W1996887331 cites W1980311540 @default.
• W1996887331 cites W1992207190 @default.
• W1996887331 cites W2004089260 @default.
• W1996887331 cites W2016978620 @default.
• W1996887331 cites W2019350782 @default.
• W1996887331 cites W2063668844 @default.
• W1996887331 cites W2067632947 @default.
• W1996887331 cites W2093070779 @default.
• W1996887331 cites W2106292925 @default.
• W1996887331 cites W2110949925 @default.
• W1996887331 cites W2132938772 @default.
• W1996887331 cites W2167571044 @default.
• W1996887331 cites W2223205229 @default.
• W1996887331 cites W2296225964 @default.
• W1996887331 cites W2412900863 @default.
• W1996887331 cites W4253916874 @default.
• W1996887331 cites W4323966288 @default.
• W1996887331 doi "https://doi.org/10.1046/j.1365-2141.2003.04153.x" @default.
• W1996887331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12648074" @default.
• W1996887331 hasPublicationYear "2003" @default.
• W1996887331 type Work @default.
• W1996887331 sameAs 1996887331 @default.
• W1996887331 citedByCount "415" @default.
• W1996887331 countsByYear W19968873312012 @default.
• W1996887331 countsByYear W19968873312013 @default.
• W1996887331 countsByYear W19968873312014 @default.
• W1996887331 countsByYear W19968873312015 @default.
• W1996887331 countsByYear W19968873312016 @default.
• W1996887331 countsByYear W19968873312017 @default.
• W1996887331 countsByYear W19968873312018 @default.
• W1996887331 countsByYear W19968873312019 @default.
• W1996887331 countsByYear W19968873312020 @default.
• W1996887331 countsByYear W19968873312021 @default.
• W1996887331 countsByYear W19968873312022 @default.
• W1996887331 countsByYear W19968873312023 @default.
• W1996887331 crossrefType "journal-article" @default.
• W1996887331 hasAuthorship W1996887331A5003907527 @default.
• W1996887331 hasAuthorship W1996887331A5014693569 @default.
• W1996887331 hasAuthorship W1996887331A5017777711 @default.
• W1996887331 hasAuthorship W1996887331A5020591121 @default.
• W1996887331 hasAuthorship W1996887331A5022052738 @default.
• W1996887331 hasAuthorship W1996887331A5031248010 @default.
• W1996887331 hasAuthorship W1996887331A5032434426 @default.
• W1996887331 hasAuthorship W1996887331A5033506735 @default.
• W1996887331 hasAuthorship W1996887331A5034029591 @default.
• W1996887331 hasAuthorship W1996887331A5044295563 @default.
• W1996887331 hasAuthorship W1996887331A5045191082 @default.
• W1996887331 hasAuthorship W1996887331A5049750813 @default.
• W1996887331 hasAuthorship W1996887331A5050171154 @default.
• W1996887331 hasAuthorship W1996887331A5067454281 @default.
• W1996887331 hasAuthorship W1996887331A5068471072 @default.
• W1996887331 hasAuthorship W1996887331A5070612759 @default.
• W1996887331 hasAuthorship W1996887331A5079834047 @default.
• W1996887331 hasAuthorship W1996887331A5080988408 @default.
• W1996887331 hasAuthorship W1996887331A5081919656 @default.
• W1996887331 hasAuthorship W1996887331A5082869425 @default.
• W1996887331 hasBestOaLocation W19968873311 @default.
• W1996887331 hasConcept C126322002 @default.
• W1996887331 hasConcept C143998085 @default.
• W1996887331 hasConcept C159110408 @default.
• W1996887331 hasConcept C2776694085 @default.
• W1996887331 hasConcept C2777767877 @default.
• W1996887331 hasConcept C2778248108 @default.
• W1996887331 hasConcept C2778534260 @default.
• W1996887331 hasConcept C2779951463 @default.

• next